Apr 8, 2026, 18:14
Simon Fletcher: The Unique Challenges PwH Face During Their Gene Therapy Journey
Simon Fletcher, Research Assistant at University of Oxford, shared a post on LinkedIn:
“In July I’m going to be in Paris at the ISTH 2026 congress sharing a novel psychosocial care framework for people undergoing gene therapy
for haemophilia.
After five years of research and clinical observation, the Exigency framework has been developed to address the unique challenges PwH face during their gene therapy journey.
What it will cover:
- Pre-treatment assessment
- Post-treatment monitoring
- Multidisciplinary care coordination strategies
- Patient support and education
Join me at the poster session on the 13th July to learn more about how this integrated approach can improve patient outcomes and quality of life.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 21:27Satish Bondala: Blood Bank and Transfusion Services – The Lifeline of Hospitals
-
Apr 15, 2026, 21:26Tareq Abadl: Understanding Thalassemia – Breaking the ‘Ordinary Anemia’ Myth
-
Apr 15, 2026, 21:24Wolfgang Miesbach: Key Message from John Semple on Platelets as Immune Cells in ITP
-
Apr 15, 2026, 21:22Manuel Gutiérrez de Ravé: Promotion to Real-World Evidence Scientist at Terumo Blood and Cell Technologies
-
Apr 15, 2026, 18:45Elias Lee: Acute PE from Subclavian VT – CT Scan Diagnosis, Radiology Interpretation, and Emergency Imaging Insights
-
Apr 15, 2026, 17:30Rivaroxaban versus Aspirin after Atrial Fibrillation Ablation – Cardiology Insights and Heart Health
-
Apr 15, 2026, 17:01Emmanuel J Favaloro: A Practical Approach to Inherited and Acquired Coagulation Disorders
-
Apr 15, 2026, 16:55Chokri Ben Lamine: VA-ECMO vs VV-ECMO Thromboembolic Events – Key Clinical Pearls
-
Apr 15, 2026, 16:54Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory